home / stock / nktr / nktr quote
Last: | $1.42 |
---|---|
Change Percent: | -2.21% |
Open: | $1.39 |
Close: | $1.42 |
High: | $1.43 |
Low: | $1.31 |
Volume: | 1,099,928 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.42 | $1.39 | $1.42 | $1.43 | $1.31 | 1,099,928 | 04-23-2024 |
$1.36 | $1.31 | $1.36 | $1.41 | $1.29 | 1,970,248 | 04-22-2024 |
$1.24 | $1.33 | $1.24 | $1.33 | $1.2 | 4,717,823 | 04-19-2024 |
$1.32 | $1.32 | $1.32 | $1.36 | $1.27 | 3,575,770 | 04-18-2024 |
$1.35 | $1.48 | $1.35 | $1.5 | $1.28 | 3,261,722 | 04-17-2024 |
$1.49 | $1.47 | $1.49 | $1.575 | $1.45 | 1,592,522 | 04-16-2024 |
$1.57 | $1.68 | $1.57 | $1.7 | $1.5 | 2,847,284 | 04-15-2024 |
$1.67 | $1.58 | $1.67 | $1.675 | $1.48 | 4,831,544 | 04-12-2024 |
$1.58 | $1.4 | $1.58 | $1.75 | $1.36 | 13,192,858 | 04-11-2024 |
$1.29 | $1.21 | $1.29 | $1.39 | $1.16 | 4,903,856 | 04-10-2024 |
$1.25 | $1.3 | $1.25 | $1.34 | $1.24 | 2,079,267 | 04-09-2024 |
$1.31 | $1.34 | $1.31 | $1.395 | $1.22 | 3,136,599 | 04-08-2024 |
$1.32 | $1.32 | $1.32 | $1.47 | $1.26 | 5,026,278 | 04-05-2024 |
$1.32 | $1.08 | $1.32 | $1.39 | $1.08 | 11,157,356 | 04-04-2024 |
$1.04 | $0.9796 | $1.04 | $1.13 | $0.95 | 3,580,635 | 04-03-2024 |
$0.95 | $0.903 | $0.95 | $1.02 | $0.89985 | 3,597,418 | 04-02-2024 |
$0.9041 | $0.93 | $0.9041 | $0.949 | $0.902 | 1,192,425 | 04-01-2024 |
$0.9342 | $0.88 | $0.9342 | $0.94 | $0.8626 | 1,316,239 | 03-29-2024 |
$0.9342 | $0.88 | $0.9342 | $0.94 | $0.8626 | 1,316,239 | 03-28-2024 |
$0.8851 | $0.88 | $0.8851 | $0.9272 | $0.84 | 1,241,878 | 03-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference PR Newswire SAN FRANCISCO ,...
Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata PR Newswire SAN FRANCISCO , March 5, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biotechnology c...
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quar...